Neogen Chemicals receives Rs 15 Cr insurance claim for Dahej fire

1 min read     Updated on 17 Jul 2026, 04:45 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Neogen Chemicals received Rs 15 Cr as the fourth on-account payment for the March 2025 fire at its Dahej facility. Total claims received now stand at Rs 155 Cr. The company reported a net loss of Rs 13.56 Cr for FY 2024-25, while production at the affected site remains suspended pending the commissioning of a replacement plant in H1FY27.

powered bylight_fuzz_icon
45832529

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited has received an additional amount of Rs 15 Cr towards the fourth on-account payment for the fire incident that occurred at its Dahej SEZ facility. The payment, received on July 16, 2026, covers loss of property, plant, and equipment based on surveyors' recommendations. The total on-account claim received to date stands at Rs 155 Cr, including this latest tranche.

The fire, which took place on March 5, 2025, affected the Multi-Purpose Plant (MPP3)- Facility, warehouse, and tank farms. The company has recognized a net loss of Rs 13.56 Cr (Rs 14.08 Cr on a consolidated basis) in FY 2024-25 after accounting for the damage and insurance receivables. The total assessed loss was Rs 348.16 Cr, against which the company recognized an insurance claim receivable of Rs 334.60 Cr.

Further settlement of claims will be determined in stages following the completion of the assessment for loss of assets, loss of profit due to business interruption, and reinstatement value. The company has not accounted for claims regarding loss of profit and excess reinstatement value over written down value, adhering to accounting conservatism.

Financial Impact and Salvage

The company has realized Rs 9.38 Cr from the sale of salvaged scrap and incurred incidental charges of Rs 1.41 Cr, which have been claimed under the insurance policy. The table below details the financial figures reported in the filing.

Metric Standalone Amount Consolidated Amount
Loss recognized Rs 348.16 Cr Rs 362.90 Cr
Insurance claim receivable Rs 334.60 Cr Rs 348.82 Cr
Net loss considered Rs 13.56 Cr Rs 14.08 Cr
Salvaged scrap sold Rs 9.38 Cr Rs 9.38 Cr
Incidental charges incurred Rs 1.41 Cr Rs 1.41 Cr

Operational Status

Production and operations at the affected MPP3 facility remain temporarily suspended. Construction of the replacement plant is progressing rapidly, with commissioning scheduled for H1FY27. To mitigate business disruption, the company has shifted the production of critical select specialty products to other sites with customer approval and is proceeding with a planned expansion at its Patancheru Plant.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-6.28%+7.35%+4.50%+64.89%+35.25%+144.37%

What is the expected timeline for receiving the remaining insurance claims related to loss of profit and reinstatement value?

How will the temporary suspension of the MPP3 facility impact Neogen Chemicals' revenue and market share in the specialty chemicals sector?

What are the estimated capital expenditures required for the construction of the replacement plant and the planned expansion at the Patancheru facility?

Neogen Chemicals promoter pledges 13.19 lakh shares

0 min read     Updated on 18 Jun 2026, 03:30 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Promoter Dr. Harin Kanani pledged 13,19,083 equity shares of Neogen Chemicals on March 30, 2026. The disclosure confirms no other encumbrances were created during FY26. The filing was submitted under Regulation 31(4) of SEBI Takeover Regulations.

powered bylight_fuzz_icon
43279234

*this image is generated using AI for illustrative purposes only.

Promoter Dr. Harin Kanani has pledged 13,19,083 equity shares of Neogen Chemicals as of March 30, 2026. The disclosure confirms this was the sole instance of encumbrance creation by the promoter group during the financial year ended March 31, 2026.

Haridas Thakarshi Kanani, a promoter of Neogen Chemicals, submitted the declaration to the stock exchanges under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing explicitly states that apart from the pledge by Dr. Harin Kanani, there was no creation, invocation, or release of encumbrance on any shares held by the promoter or persons acting in concert during FY26.

The disclosure was addressed to BSE Limited and National Stock Exchange of India Limited. Copies of the submission were forwarded to the Audit Committee and Unnati Kanani, the Company Secretary and Compliance Officer of Neogen Chemicals.

Key Disclosure Details

Particulars Details
Promoter Name Dr. Harin Kanani
Shares Pledged 13,19,083 equity shares
Date of Pledge March 30, 2026
Regulation SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Financial Year Ended March 31, 2026

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-6.28%+7.35%+4.50%+64.89%+35.25%+144.37%

What specific purpose will the funds raised from this pledge be utilized for?

How might this increase in pledged shares impact the promoter's voting rights or control if market volatility triggers a margin call?

Does this pledge signal a need for liquidity within the promoter group for personal investments or other corporate ventures?

More News on Neogen Chemicals

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+35.25%